Association between functional promoter polymorphisms of macrophage migration inhibitory factor (MIF) gene and ulcerative colitis in Japan

Cytokine

Volumn 51, Issue 2, 2010, Pages 173-177

  Shiroeda, Hisakazu ^a   Tahara, Tomomitsu ^b   Nakamura, Masakatsu ^b   Shibata, Tomoyuki ^b   Nomura, Tomoe ^a   Yamada, Hideto ^a   Hayashi, Ranji ^a   Saito, Takashi ^a   Yamada, Masayoshi ^a   Fukuyama, Tomoki ^a   Otsuka, Toshimi ^a   Yano, Hirokazu ^a   Ozaki, Kazuaki ^a   Tsuchishima, Mutsumi ^a   Tsutsumi, Mikihiro ^a   Arisawa, Tomiyasu ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Macrophage migration inhibitory factor (MIF); Promoter polymorphism; Ulcerative colitis

Indexed keywords

MACROPHAGE MIGRATION INHIBITION FACTOR; MICROSATELLITE DNA;

ARTICLE; COLITIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR; SINGLE STRAND CONFORMATION POLYMORPHISM; ULCERATIVE COLITIS; ADULT; GENETIC PREDISPOSITION; GENETICS; INFLAMMATION; MIDDLE AGED;

ADULT; COLITIS, ULCERATIVE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLAMMATION; JAPAN; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROMOTER REGIONS, GENETIC;

EID: 77954086857     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2010.05.003     Document Type: Article

References (36)

1. Podolsky D.K. Inflammatory bowel disease. N Engl J Med 2002, 347:417-429. [PMID: 12167685].
2. Head K.A., Jurenka J.S. Inflammatory bowel disease part I: ulcerative colitis-pathophysiology and conventional and alternative treatment options. Altern Med Rev 2003, 8:247-283. PMID: 12946238.
3. Tanaka M., Kazuma K. Ulcerative colitis: factors affecting difficulties of life and psychological well being of patients in remission. J Clin Nurs 2005, 14:65-73. PMID: 15656850.
4. Newman B., Siminovitch K.A. Recent advances in the genetics of inflammatory bowel disease. Curr Opin Gastroenterol 2005, 21:401-407. PMID: 15930978.
5. Bloom B.R., Bennett B. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 1966, 153:80-82. PMID: 5938421.
6. David J.R. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci USA 1966, 56:72-77. PMID: 5229858.
7. Weiser W.Y., Temple P.A., Witek-Giannotti J.S., Remold H.G., Clark S.C., David J.R. Molecular cloning of a cDNA encoding a human macrophage migration inhibitory factor. Proc Natl Acad Sci USA 1989, 86:7522-7526. PMID: 2552447.
8. Lue H., Kleemann R., Calandra T., Roger T., Bernhagen J. Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease. Microb Infect 2002, 4:449-460. PMID: 11932196.
9. Calandra T., Echtenacher B., Roy D.L., Pugin J., Metz C.N., Hultner L., et al. Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat Med 2000, 6:164-170. PMID: 10655104.
10. Donnelly S.C., Haslett C., Reid P.T., Grant I.S., Wallace W.A., Metz C.N., et al. Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat Med 1997, 3:320-323. PMID: 9055860.
11. Murakami H., Akbar S.M., Matsui H., Horiike N., Onji M. Macrophage migration inhibitory factor activates antigen-presenting dendritic cells and induces inflammatory cytokines in ulcerative colitis. Clin Exp Immunol 2002, 128:504-510. PMID: 12109441.
12. Ishiguro Y., Yamagata K., Sakuraba H., Munakata A., Nakane A., Morita T., et al. Macrophage migration inhibitory factor and activator protein-1 in ulcerative colitis. Ann N Y Acad Sci 2004, 1029:348-349. PMID: 15681778.
13. Donn R., Alourfi Z., De Benedetti F., Meazza C., Zeggini E., Lunt M., et al. Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. Arthritis Rheum 2002, 46:2402-2409. PMID: 12355488.
14. Amoli M.M., Donn R.P., Thomson W., Hajeer A.H., Garcia-Porrua C., Lueiro M., et al. Macrophage migration inhibitory factor gene polymorphism is associated with sarcoidosis in biopsy proven erythema nodosum. J Rheumatol 2002, 29:1671-1673. PMID: 12180727.
15. Baugh J.A., Chitnis S., Donnelly S.C., Monterio J., Lin X., Plant B.J., et al. A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis. Genes Immun 2002, 3:170-176. PMID: 12070782.
16. Nohara H., Okayama N., Inoue N., Koike Y., Fujimura K., Suehiro Y., et al. Association of the -173G/C polymorphism of the macrophage migration inhibitory factor gene with ulcerative colitis. J Gastroenterol 2004, 393:242-246. PMID: 15065001.
17. Griga T., Wilkens C., Wirkus N., Epplen J., Schmiegel W., Klein W. A polymorphism in the macrophage migration inhibitory factor gene is involved the genetic prediction of Crohn's disease and associated with cumulative steroid doses. Hepatogastroenterology 2007, 54:784-786. PMID: 17591062.
18. Fei B.Y., Lv H.X., Yang J.M., Ye Z.Y. Association of MIF-173 gene polymorphism with inflammatory bowel disease in Chinese Han population. Cytokine 2008, 41:44-47. PMID: 18054247.
19. Podolsky D.K. Inflammatory bowel disease 2. N Engl J Med 1991, 325:928-937. PMID: 1886623.
20. Langholz E., Munkholm P., Davidsen M., Binder V. Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology 1994, 107:3-11.
21. Arisawa T., Tahara T., Shibata T., Nagasaka M., Nakamura M., Kamiya Y., et al. Functional promoter polymorphism of the macrophage migration inhibitory factor gene in gastric carcinogenesis. Oncol Rep 2008, 19:223-228. PMID: 18097599.
22. Arisawa T., Tahara T., Shibata T., Nagasaka M., Nakamura M., Kamiya Y., et al. Nrf2 gene promoter polymorphism is associated with ulcerative colitis in a Japanese population. Hepatogastroenterology 2008, 55:394-397. PMID: 18613373.
23. Arisawa T., Tahara T., Shibata T., Nagasaka M., Nakamura M., Kamiya Y., et al. The influence of polymorphism of interleukin-17A and interleukin-17F genes on the susceptibility to ulcerative colitis. J Clin Immunol 2008, 28:44-49. PMID: 17828618.
24. Swope M.D., Lolis E. Macrophage migration inhibitory factor: cytokine, hormone, or enzyme?. Rev Physiol Biochem Pharmacol 1999, 139:1-32. PMID: 10453691.
25. Leech M., Metz C., Hall P., Hutchinson P., Ganis K., Smith M., et al. Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids. Arthritis Rheum 1999, 42:1601-1608. PMID: 10446857.
26. Bernhagen J., Calandra T., Bucala R. The emerging role of MIF in septic shock and infection. Biotherapy 1995, 8:123-127. PMID: 8924353.
27. Donnelly S.C., Bucala R., Metz C.N., Grant I.S., Robertson C.R., Hastett C. Macrophage migration inhibitory factor and acute lung injury. Chest 1999, 116(Suppl. 1):111S. PMID: 16424626.
28. Tulic M.K., Wale J.L., Holt P.G., Sly P.D. Modification of the inflammatory response to allergen challenge after exposure to bacterial lipopolysaccharide. Am J Respir Cell Mol Biol 2000, 22:604-612. PMID: 10783133.
29. Gereda J.E., Leung D.Y., Thatayatikom A., Streib J.E., Price M.R., Klinnert M.D., et al. Relation between house-dust endotoxin exposure, type-1 T-cell development, and allergen sensitization in infants at high risk of asthma. Lancet 2000, 355:1680-1683. PMID: 10905243.
30. Murakami H., Akbar S.M., Matsui H., Onji M. Macrophage migration inhibitory factor in the sera and at the colonic mucosa in patients with ulcerative colitis: clinical implications and pathogenic significance. Eur J Clin Invest 2001, 31:337-343. PMID: 11298781.
31. Calandra T., Bernhagen J., Mitchell R.A., Bucala R. Macrophage is an important and previously unrecognized source of macrophage-migration inhibitory factor. J Exp Med 1994, 179:1895-1902. PMID: 8195715.
32. Bacher M., Metz C.N., Calandra T., Mayer K., Chesney J., Lohoff M., et al. An essential regulatory rale for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci USA 1996, 93:7849-7854. PMID: 8755565.
33. Benigni F., Atsumi T., Calandra T., Metz C., Echtenacher B., Peng T., et al. The proinflammatory mediator macrophage migration inhibitory factor induces glucose catabolism in muscle. J Clin Invest 2000, 106:1291-1300. PMID: 11086030.
34. Abe R., Peng T., Sailors J., Bucala R., Metz C.N. Regulation of the CTL response by macrophage migration inhibitory factor. J Immunol 2001, 166:747-753. PMID: 11145646.
35. Renner P., Roger T., Calandra T. Macrophage migration inhibitory factor: gene polymorphisms and susceptibility to inflammatory diseases. Clin Infect Dis 2005, 41(Suppl. 7):S513-S519. PMID: 16237655.
36. Hizawa N., Yamaguchi E., Takahashi D., Nishihara J., Nishimura M. Functional polymorphisms in the promoter region of macrophage migration inhibitory factor and atopy. Am J Respir Crit Care Med 2004, 169:1014-1018. PMID: 14962818.